(CCM) Concord Medical Holdings - Ratings and Ratios

Exchange: NYSE • Country: China • Currency: USD • Type: Common Stock • ISIN: US2062771058

CCM: Cancer, Radiotherapy, Imaging, Equipment, Hospitals, Diagnostics, Research

Concord Medical Services Holdings Limited (NYSE:CCM) is a leading healthcare provider in China, specializing in radiotherapy and diagnostic imaging services. Established in 1997 and headquartered in Beijing, the company operates through two primary segments: Network and Hospital. Its network includes advanced cancer treatment centers equipped with cutting-edge technologies such as linear accelerators, proton therapy systems, and gamma knife radiosurgery. Additionally, the company offers diagnostic imaging services, including positron emission tomography-computed tomography (PET-CT) and magnetic resonance imaging (MRI) scanners.

Concord Medical extends beyond clinical services, providing comprehensive support to healthcare professionals. This includes developing treatment protocols, organizing joint diagnoses, and assisting in the recruitment and compensation of medical personnel. The company also leases radiotherapy and diagnostic equipment to hospitals and offers premium cancer and proton treatment services. Its teleconsultation and medical information technology services further enhance accessibility and efficiency in patient care. Moreover, Concord Medical operates specialty cancer hospitals, delivering a range of services including radiation therapy, imaging, laboratory testing, and inpatient care.

As a key player in Chinas healthcare sector, Concord Medical Services Holdings Limited is well-positioned to address the growing demand for advanced oncology treatments and diagnostic solutions. Its integrated approach combines state-of-the-art technology, clinical expertise, and operational support, making it a critical partner for hospitals and healthcare providers in China.

3-Month Forecast: Based on the provided and , here is the outlook for Concord Medical Services Holdings Limited (NYSE:CCM):

- Price Movement: The stock is currently trading below its SMA 20 and SMA 50, suggesting bearish momentum. With the SMA 200 at 6.35, further downside is likely if the stock fails to reclaim the 4.88 level. - Volatility: The ATR of 0.39 indicates moderate volatility, meaning price swings of 5-10% could occur over the next quarter. - Valuation: The P/B ratio of 3.00 suggests the stock is trading at a premium relative to its book value, which could limit upside potential. Meanwhile, the P/S ratio of 0.05 indicates undervaluation relative to sales. - Earnings Potential: With an RoE of 15.01, the company demonstrates strong profitability. However, the lack of forward P/E data makes it challenging to assess future earnings growth. - Volume: Average trading volume of 5,823 shares over 20 days indicates low liquidity, which could amplify price movements in response to news or catalysts. - Target Range: Technical indicators suggest a potential trading range between $3.92 and $4.70 over the next three months, with key resistance at $4.88 and support at $3.92. - Fundamental Outlook: While the companys operational performance is strong, its valuation metrics and low trading volume may lead to sideways or slightly bearish movement in the near term. Investors should monitor earnings reports and industry trends for potential catalysts.

Additional Sources for CCM Stock

CCM Stock Overview

Market Cap in USD 23m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2009-12-11

CCM Stock Ratings

Growth 5y -76.4%
Fundamental -52.5%
Dividend 1.31%
Rel. Strength Industry 10
Analysts -
Fair Price Momentum 3.44 USD
Fair Price DCF -

CCM Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 4.4%

CCM Growth Ratios

Growth Correlation 3m -3.9%
Growth Correlation 12m -44.3%
Growth Correlation 5y -83.7%
CAGR 5y -23.87%
CAGR/Max DD 5y -0.26
Sharpe Ratio 12m -0.22
Alpha 11.97
Beta -0.80
Volatility 96.72%
Current Volume 8.6k
Average Volume 20d 1.2k
What is the price of CCM stocks?
As of March 15, 2025, the stock is trading at USD 4.44 with a total of 8,590 shares traded.
Over the past week, the price has changed by +3.02%, over one month by -6.92%, over three months by -9.20% and over the past year by +11.00%.
Is Concord Medical Holdings a good stock to buy?
No, based on ValueRay Fundamental Analyses, Concord Medical Holdings (NYSE:CCM) is currently (March 2025) a stock to sell. It has a ValueRay Fundamental Rating of -52.54 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCM as of March 2025 is 3.44. This means that CCM is currently overvalued and has a potential downside of -22.52%.
Is CCM a buy, sell or hold?
Concord Medical Holdings has no consensus analysts rating.
What are the forecast for CCM stock price target?
According to ValueRays Forecast Model, CCM Concord Medical Holdings will be worth about 3.7 in March 2026. The stock is currently trading at 4.44. This means that the stock has a potential downside of -16.44%.
Issuer Forecast Upside
Wallstreet Target Price 1.2 -73%
Analysts Target Price - -
ValueRay Target Price 3.7 -16.4%